Piper Megan E, Federmen E Belle, McCarthy Danielle E, Bolt Daniel M, Smith Stevens S, Fiore Michael C, Baker Timothy B
Center for Tobacco Research and Intervention, School of Medicine and Public Health, University of Wisconsin--Madison, Madison, WI 53711-2027, USA.
J Abnorm Psychol. 2008 Feb;117(1):94-105. doi: 10.1037/0021-843X.117.1.94.
Various theories have proposed mechanisms for drug motivation and relapse. For instance, negative reinforcement theories focus on the alleviation of withdrawal. However, other theories and some data cast doubt on the importance of withdrawal as a motivator of addictive drug use. Using data from a randomized double-blind placebo-controlled smoking cessation treatment study (N=608), this research examined the impact of withdrawal on drug motivation and the ability to maintain abstinence. Withdrawal was experimentally manipulated by randomly assigning participants to receive active bupropion versus placebo. Mediation analyses revealed that active bupropion reduced the amount of withdrawal and craving that individuals reported in the 1st week post quit; modest support was also found for smaller declines in positive affect. These effects, in turn, were all positively associated with posttreatment abstinence. These results implicate withdrawal as an important factor in motivating persistent tobacco use.
各种理论都提出了关于药物动机和复吸的机制。例如,负强化理论关注戒断症状的缓解。然而,其他理论和一些数据对戒断作为成瘾性药物使用动机的重要性提出了质疑。本研究利用一项随机双盲安慰剂对照戒烟治疗研究(N = 608)的数据,考察了戒断对药物动机和维持戒烟状态能力的影响。通过随机分配参与者接受活性安非他酮或安慰剂,对戒断进行了实验性操纵。中介分析表明,活性安非他酮减少了个体在戒烟后第1周报告的戒断症状和渴望程度;对于积极情绪的较小下降也有适度的支持。反过来,这些效应都与治疗后的戒烟状态呈正相关。这些结果表明戒断是促使持续吸烟的一个重要因素。